Horizon Discovery Group, a global leader in gene editing and gene modulation technologies, announced that it has entered into a partnership with Rutgers University to develop and commercialize a novel gene editing technology, known as base editing. The technology potentially has applications in the development of new cell therapies and will augment Horizon’s research tools and services. Read more here.